PolyPeptide Group AG

SIX:PPGN.SW

32.15 (CHF) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

202320222021202020192018
Operating Activities:
Net Income -51.447.76747.25831.33525.73723.82
Depreciation & Amortization 30.46924.02618.71316.08515.80814.422
Deferred Income Tax 3.13513.19128.7000
Stock Based Compensation 0.8421.1551.208000
Change In Working Capital 46.199-14.346-29.908-43.53711.413-15.006
Accounts Receivables -29.34618.783-12.239-21.4368.165-10.678
Inventory 15.511-33.129-17.669-22.101-1.2312.034
Accounts Payables 29.3464.9892.257-5.363-8.16510.678
Other Working Capital 30.688-4.989-2.2575.36312.644-17.04
Other Non Cash Items 7.28-26.333-8.61945.5992.642-0.293
Operating Cash Flow 36.4855.4657.35249.48255.622.943
Investing Activities:
Investments In Property Plant And Equipment -56.733-75.099-73.961-40.621-19.705-18.298
Acquisitions Net 00004.4440
Purchases Of Investments 00002.181-0.296
Sales Maturities Of Investments 000030
Other Investing Activites -2.779-3.336-6.884-1.939-2.181-4.068
Investing Cash Flow -59.512-78.435-80.845-42.56-12.261-18.594
Financing Activities:
Debt Repayment -55.172-3.265-41.371-9.083-8.009-6.863
Common Stock Issued 017.198182.141000
Common Stock Repurchased 0-13.933-5.4640-16.60
Dividends Paid 0-9.6710000
Other Financing Activities 139.719-17.198130.9282.353-11.3283.528
Financing Cash Flow 84.547-26.869130.928-6.73-35.937-3.335
Other Information:
Effect Of Forex Changes On Cash -3.3421.06911.66-0.4920.069-0.104
Net Change In Cash 58.178-98.775119.095-0.37.4710.91
Cash At End Of Period 95.70637.528136.30317.20817.50810.037